Hydrolysis of polysorbate 20 and 80 by a range of carboxylester hydrolases

AC McShan, P Kei, JA Ji, DC Kim… - PDA journal of …, 2016 - journal.pda.org
Degradation of the surfactant polysorbate (PS) by enzyme impurities has been previously
suggested as a mechanism for the formation of visible and subvisible particles that affect …

A comprehensive assessment of all-oleate polysorbate 80: free fatty acid particle formation, interfacial protection and oxidative degradation

…, R Taing, J Chu, A Sreedhara, A Kannan, P Kei… - Pharmaceutical …, 2021 - Springer
Purpose Enzymatic polysorbate (PS) degradation and resulting free fatty acid (FFA) particles
are detrimental to biopharmaceutical drug product (DP) stability. Different types and grades …

[PDF][PDF] Weak interactions govern the viscosity of concentrated antibody solutions: high-throughput analysis using the diffusion interaction parameter

BD Connolly, C Petry, S Yadav, B Demeule, N Ciaccio… - Biophysical journal, 2012 - cell.com
Weak protein-protein interactions are thought to modulate the viscoelastic properties of
concentrated antibody solutions. Predicting the viscoelastic behavior of concentrated antibodies …

Auristatin antibody drug conjugate physical instability and the role of drug payload

YT Adem, KA Schwarz, E Duenas… - Bioconjugate …, 2014 - ACS Publications
The conjugation of hydrophobic cytotoxic agents such as monomethyl auristatin E (MMAE)
to the interchain sulfhydryl groups of monoclonal antibodies (Mabs) through a protease-labile …

Profiling antibody drug conjugate positional isomers: a system-of-equations approach

LN Le, JMR Moore, J Ouyang, X Chen… - Analytical …, 2012 - ACS Publications
Antibody drug conjugates enable the targeted delivery of potent chemotherapeutic agents
directly to cancerous cells. They are made by the chemical conjugation of cytotoxins to …

Investigation into temperature-induced aggregation of an antibody drug conjugate

NS Beckley, KP Lazzareschi, HW Chih… - Bioconjugate …, 2013 - ACS Publications
Conjugation of an antibody to a drug can produce heterogeneous species that may have
different physical stabilities and safety profiles. We explored the effect of thermal stress on the …

[HTML][HTML] Identification of subvisible particles in biopharmaceutical formulations using Raman spectroscopy provides insight into polysorbate 20 degradation pathway

M Saggu, J Liu, A Patel - Pharmaceutical research, 2015 - Springer
Pervina Kei and John Wang are acknowledged for kindly providing enzymatically digested
polysorbate 20 samples. Kevin Lu is acknowledged for his support with the HPLC analysis. …

[BOOK][B] Microrheology for protein therapeutics development

LL Josephson - 2016 - search.proquest.com
… from gRED Center of Advance Light Microscopy for the facility setup; Catherine Shi for
showing me around and teaching me all the tricks; and Eileen, Nate, Michelle, Kate, and Pervina

Impact of poloxamer 188 material attributes on proteinaceous visible particle formation in liquid monoclonal antibody formulations

K Soeda, M Fukuda, M Takahashi, H Imai, K Arai… - Journal of …, 2022 - Elsevier
Surfactants such as Poloxamer 188 (PX188) play an important role in controlling particle
formation in biotherapeutic formulations due to interfacial stresses. This study demonstrates for …

[BOOK][B] Venantius Fortunatus: Vita Sancti MartiniPrologue and Books I–II

NM Kay - 2020 - books.google.com
This volume provides a new critical text of the Prologue and the first two books of Venantius
Fortunatus' Vita Sancti Martini, a work, written in the latter half of the sixth century, which …